Insights on the Diabetes Therapeutics Global Market to 2030 - Rising Prevalence of Diabetes, High Obesity, Sedentary Lifestyles and Other Chronic Conditions is Driving Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Diabetes Therapeutics Market By Product: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.

The global diabetes therapeutics market was valued at $1,258,936.4 million in 2020, and is projected to reach $3,390,002.1 million by 2030, registering a CAGR of 10.4% from 2021 to 2030.

Diabetes is a chronic metabolic disorder in which there are abnormalities in blood glucose levels. Diabetes therapeutics are drugs used by diabetic patients to conserve the blood glucose levels in the body.

The global diabetes therapeutics market is expected to register substantial growth in the near future, owing to rise in prevalence of diabetes, high obesity, sedentary lifestyles, and other chronic conditions.

For instance, according to International Diabetes Federation (IDF),Diabetes Atlas, in 2021, approximately 537 million adults (20-79 years of age) were living with diabetes.

Furthermore, rise in geriatric population led to an increase in growth of diabetes therapeutics market. However, side effects caused by anti-diabetes medication hamper the market growth during the forecast period.

Conversely, increase in funding for R&D activities in diabetes sector is expected to offer remunerative opportunities for market players.

Key Benefits For Stakeholders

• The report provides an in-depth analysis of the global diabetes therapeutics market size along with the current trends and future estimations to elucidate the future investment pockets.
• It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
• A comprehensive analysis of the region helps to understand the regional market, facilitate strategic business planning, and determine prevailing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global diabetes therapeutics market growth.

Key Market Segments

By Product

• Injectables
• Oral antidiabetic Drugs

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• China
• Japan
• India
• Australia
• Rest Of Asia Pacific
• LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA

Key Market Players

• AstraZeneca plc
• Boehringer Ingelheim GmbH
• Eli Lilly and Company
• GlaxoSmithKline plc
• Novartis AG
• Novo Nordisk
• Sanofi S.A.
• Takeda Pharmaceutical Company Limited
• Johnson and Johnson
• Merck and Co. Inc.

For more information about this report visit https://www.researchandmarkets.com/r/4xn0yl